MCL
CUE icon

MIRAMONTES CAPITAL, LLC’s Cue Biopharma CUE Stock Holding History

MIRAMONTES CAPITAL, LLC’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-868
Closed -$5.99K – 142
2026
Q1 		$5.99K Hold
868
– – ﹤0.01% 122
2025
Q4 		$7.95K Buy
+868
New +$15.9K ﹤0.01% 126

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

MIRAMONTES CAPITAL, LLC's CUE Position: Q2 2026 in Review

MIRAMONTES CAPITAL, LLC sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 868 shares — an estimated $5.99K sold.

MIRAMONTES CAPITAL, LLC first reported a position in CUE in Q4 2025 and held it in 2 quarters. The position peaked at $7.95K in Q4 2025. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • MIRAMONTES CAPITAL, LLC reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • MIRAMONTES CAPITAL, LLC sold 868 Cue Biopharma shares in Q2 2026, an estimated $5.99K.
  • MIRAMONTES CAPITAL, LLC first reported a position in Cue Biopharma in Q4 2025 and held it in 2 quarters.
  • MIRAMONTES CAPITAL, LLC's Cue Biopharma position peaked at $7.95K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on MIRAMONTES CAPITAL, LLC's 13F filing for Q2 2026, filed 9 Sep 2026.